Plasma Fractionation Market Trends: Ensuring Safety, Quality, and Supply

The global healthcare landscape is evolving rapidly, with rare chronic diseases and immune-related disorders emerging as critical areas of concern. At the heart of many advanced therapies addressing these conditions lies plasma fractionation a highly specialized process that transforms human blood plasma into essential, life-saving medicines. According to industry estimates, the global plasma fractionation market was valued at US$ 24.1 billion in 2022 and is projected to reach US$ 42.6 billion by 2031, expanding at a CAGR of 6.7% from 2023 to 2031. This steady growth reflects rising medical need, scientific progress, and expanding plasma collection infrastructure worldwide. Understanding Plasma Fractionation and Its Medical Importance Plasma fractionation is the large-scale process of separating plasma into its key protein components, such as immunoglobulins, albumin, and coagulation factors. These proteins form the backbone of therapies used to treat a wide range of conditions, in